Is SAVAW or VYM a better dividend investment in 2026?

SAVAW currently yields 6666.67% with a 5% 5-year dividend growth rate. VYM yields 2.37% with 7.8% growth. The better choice depends on your goal: SAVAW offers higher current income.

What is the dividend yield difference between SAVAW and VYM?

SAVAW has a forward dividend yield of 6666.67% ($2.00/share annually). VYM yields 2.37% ($3.51/share annually). The yield gap is 6664.30 percentage points.

Home › Compare › SAVAW vs VYM

SAVAW vs VYM: Dividend Comparison 2026

SAVAW yields 6666.67% · VYM yields 2.37%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SAVAW wins by $1028095347812062.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SAVAW

● Live price

6666.67%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1028095347812062.00M

Annual income

$998,628,545,336,266,700,000.00

Full SAVAW calculator →

VYM

Vanguard High Dividend Yield ETF

● Live price

2.37%

Share price

$148.10

Annual div

$3.51

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.8K

Annual income

$272.94

Full VYM calculator →

Portfolio growth — SAVAW vs VYM

📍 SAVAW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SAVAW	VYM
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SAVAW + VYM cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SAVAW pays

VYM pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SAVAW

Annual income on $10K today (after 15% tax)

$566,666.67/yr

After 10yr DRIP, annual income (after tax)

$848,834,263,535,826,600,000.00/yr

VYM

Annual income on $10K today (after 15% tax)

$201.60/yr

After 10yr DRIP, annual income (after tax)

$232.00/yr

At 15% tax rate, SAVAW beats the other by $848,834,263,535,826,600,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SAVAW + VYM for your $10,000?

SAVAW: 50%VYM: 50%

100% VYM50/50100% SAVAW

Portfolio after 10yr

$514047673906031.00M

Annual income

$499,314,272,668,133,360,000.00/yr

Blended yield

97.13%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SAVAW buys

VYM buys

No recent congressional trades found for SAVAW or VYM in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSAVAWVYM

Forward yield	6666.67% ✓	2.37%
Annual dividend / share	$2.00	$3.51 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$1028095347812062.00M ✓	$27.8K
Annual income after 10y	$998,628,545,336,266,700,000.00 ✓	$272.94
Total dividends collected	$1026118102492338.88M ✓	$2.6K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: SAVAW vs VYM ($10,000, DRIP)

Year	SAVAW Portfolio	SAVAW Income/yr	VYM Portfolio	VYM Income/yr	Gap
1← crossover	$677,367	$666,666.67	$11,147	$237.17	+$666.2K → SAVAW
2	$42,928,313	$42,203,530.63	$12,404	$242.33	+$42.92M → SAVAW
3	$2,545,616,701	$2,499,683,405.64	$13,780	$247.16	+$2545.60M → SAVAW
4	$141,255,910,403	$138,532,100,533.89	$15,285	$251.67	+$141255.90M → SAVAW
5	$7,335,374,338,812	$7,184,230,514,680.15	$16,932	$255.88	+$7335374.32M → SAVAW
6	$356,516,885,536,661	$348,668,034,994,132.70	$18,733	$259.81	+$356516885.52M → SAVAW
7	$16,218,956,689,966,618	$15,837,483,622,442,392.00	$20,701	$263.46	+$16218956689.95M → SAVAW
8	$690,711,023,145,868,900	$673,356,739,487,604,600.00	$22,852	$266.86	+$690711023145.85M → SAVAW
9	$27,539,067,734,387,980,000	$26,800,006,939,621,900,000.00	$25,201	$270.01	+$27539067734387.95M → SAVAW
10	$1,028,095,347,812,062,000,000	$998,628,545,336,266,700,000.00	$27,768	$272.94	+$1028095347812062.00M → SAVAW

SAVAW vs VYM: Complete Analysis 2026

SAVAW — Stock

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.

Full SAVAW Calculator →

VYM — ETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →

📬

Get this SAVAW vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SAVAW vs SCHD SAVAW vs JEPI SAVAW vs O SAVAW vs KO SAVAW vs MAIN SAVAW vs VIG SAVAW vs DGRO SAVAW vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.